The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease

Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson’s disease (PD) and must be developed concurrently because of their interdependent relationship: biomarkers for the early detection of disease (i.e., prior to overt neurodegeneration) are nece...

Descripción completa

Detalles Bibliográficos
Autores principales: Polissidis, Alexia, Petropoulou-Vathi, Lilian, Nakos-Bimpos, Modestos, Rideout, Hardy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355671/
https://www.ncbi.nlm.nih.gov/pubmed/32560161
http://dx.doi.org/10.3390/biom10060912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355671/
https://www.ncbi.nlm.nih.gov/pubmed/32560161
http://dx.doi.org/10.3390/biom10060912

Ejemplares similares